Intranasal delivery of caspase-9 inhibitor reduces caspase-6-dependent axon/neuron loss and improves neurological function after stroke

Nsikan Akpan, Esther Serrano-Saiz, Brad E. Zacharia, Marc L. Otten, Andrew F. Ducruet, Scott J. Snipas, Wen Liu, Jennifer Velloza, Greg Cohen, Sergeyi A. Sosunov, William H. Frey, Guy S. Salvesen, E. Sander Connolly, Carol M. Troy

Research output: Contribution to journalArticle

63 Citations (Scopus)

Abstract

Despite extensive research to develop an effective neuroprotective strategy for the treatment of ischemic stroke, therapeutic options remain limited. Although caspase-dependent death is thought to play a prominent role in neuronal injury, direct evidence of active initiator caspases in stroke and the functional relevance of this activity have not previously been shown. Using an unbiased caspase-trapping technique in vivo, weisolated active caspase-9 from ischemic rat brain within 1 h of reperfusion. Pathogenic relevance of active caspase-9 was shown by intranasal delivery of a novel cell membrane-penetrating highly specific inhibitor for active caspase-9 at 4 h postreperfusion (hpr). Caspase-9 inhibition provided neurofunctional protection and established caspase-6 as its downstream target. The temporal and spatial pattern of expression demonstrates that neuronal caspase-9 activity induces caspase-6 activation, mediating axonal loss by 12 hpr followed by neuronal death within 24 hpr. Collectively, these results support selective inhibition of these specific caspases as an effective therapeutic strategy for stroke.

Original languageEnglish (US)
Pages (from-to)8894-8904
Number of pages11
JournalJournal of Neuroscience
Volume31
Issue number24
DOIs
StatePublished - Jun 15 2011

Fingerprint

Caspase 6
Caspase Inhibitors
Caspase 9
Axons
Stroke
Neurons
Caspases
Initiator Caspases
Reperfusion
Cell Membrane
Wounds and Injuries
Brain
Therapeutics
Research

All Science Journal Classification (ASJC) codes

  • Neuroscience(all)

Cite this

Akpan, Nsikan ; Serrano-Saiz, Esther ; Zacharia, Brad E. ; Otten, Marc L. ; Ducruet, Andrew F. ; Snipas, Scott J. ; Liu, Wen ; Velloza, Jennifer ; Cohen, Greg ; Sosunov, Sergeyi A. ; Frey, William H. ; Salvesen, Guy S. ; Connolly, E. Sander ; Troy, Carol M. / Intranasal delivery of caspase-9 inhibitor reduces caspase-6-dependent axon/neuron loss and improves neurological function after stroke. In: Journal of Neuroscience. 2011 ; Vol. 31, No. 24. pp. 8894-8904.
@article{6b9cba2b517d4cec8fbcb5186c77c4ca,
title = "Intranasal delivery of caspase-9 inhibitor reduces caspase-6-dependent axon/neuron loss and improves neurological function after stroke",
abstract = "Despite extensive research to develop an effective neuroprotective strategy for the treatment of ischemic stroke, therapeutic options remain limited. Although caspase-dependent death is thought to play a prominent role in neuronal injury, direct evidence of active initiator caspases in stroke and the functional relevance of this activity have not previously been shown. Using an unbiased caspase-trapping technique in vivo, weisolated active caspase-9 from ischemic rat brain within 1 h of reperfusion. Pathogenic relevance of active caspase-9 was shown by intranasal delivery of a novel cell membrane-penetrating highly specific inhibitor for active caspase-9 at 4 h postreperfusion (hpr). Caspase-9 inhibition provided neurofunctional protection and established caspase-6 as its downstream target. The temporal and spatial pattern of expression demonstrates that neuronal caspase-9 activity induces caspase-6 activation, mediating axonal loss by 12 hpr followed by neuronal death within 24 hpr. Collectively, these results support selective inhibition of these specific caspases as an effective therapeutic strategy for stroke.",
author = "Nsikan Akpan and Esther Serrano-Saiz and Zacharia, {Brad E.} and Otten, {Marc L.} and Ducruet, {Andrew F.} and Snipas, {Scott J.} and Wen Liu and Jennifer Velloza and Greg Cohen and Sosunov, {Sergeyi A.} and Frey, {William H.} and Salvesen, {Guy S.} and Connolly, {E. Sander} and Troy, {Carol M.}",
year = "2011",
month = "6",
day = "15",
doi = "10.1523/JNEUROSCI.0698-11.2011",
language = "English (US)",
volume = "31",
pages = "8894--8904",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "24",

}

Akpan, N, Serrano-Saiz, E, Zacharia, BE, Otten, ML, Ducruet, AF, Snipas, SJ, Liu, W, Velloza, J, Cohen, G, Sosunov, SA, Frey, WH, Salvesen, GS, Connolly, ES & Troy, CM 2011, 'Intranasal delivery of caspase-9 inhibitor reduces caspase-6-dependent axon/neuron loss and improves neurological function after stroke', Journal of Neuroscience, vol. 31, no. 24, pp. 8894-8904. https://doi.org/10.1523/JNEUROSCI.0698-11.2011

Intranasal delivery of caspase-9 inhibitor reduces caspase-6-dependent axon/neuron loss and improves neurological function after stroke. / Akpan, Nsikan; Serrano-Saiz, Esther; Zacharia, Brad E.; Otten, Marc L.; Ducruet, Andrew F.; Snipas, Scott J.; Liu, Wen; Velloza, Jennifer; Cohen, Greg; Sosunov, Sergeyi A.; Frey, William H.; Salvesen, Guy S.; Connolly, E. Sander; Troy, Carol M.

In: Journal of Neuroscience, Vol. 31, No. 24, 15.06.2011, p. 8894-8904.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Intranasal delivery of caspase-9 inhibitor reduces caspase-6-dependent axon/neuron loss and improves neurological function after stroke

AU - Akpan, Nsikan

AU - Serrano-Saiz, Esther

AU - Zacharia, Brad E.

AU - Otten, Marc L.

AU - Ducruet, Andrew F.

AU - Snipas, Scott J.

AU - Liu, Wen

AU - Velloza, Jennifer

AU - Cohen, Greg

AU - Sosunov, Sergeyi A.

AU - Frey, William H.

AU - Salvesen, Guy S.

AU - Connolly, E. Sander

AU - Troy, Carol M.

PY - 2011/6/15

Y1 - 2011/6/15

N2 - Despite extensive research to develop an effective neuroprotective strategy for the treatment of ischemic stroke, therapeutic options remain limited. Although caspase-dependent death is thought to play a prominent role in neuronal injury, direct evidence of active initiator caspases in stroke and the functional relevance of this activity have not previously been shown. Using an unbiased caspase-trapping technique in vivo, weisolated active caspase-9 from ischemic rat brain within 1 h of reperfusion. Pathogenic relevance of active caspase-9 was shown by intranasal delivery of a novel cell membrane-penetrating highly specific inhibitor for active caspase-9 at 4 h postreperfusion (hpr). Caspase-9 inhibition provided neurofunctional protection and established caspase-6 as its downstream target. The temporal and spatial pattern of expression demonstrates that neuronal caspase-9 activity induces caspase-6 activation, mediating axonal loss by 12 hpr followed by neuronal death within 24 hpr. Collectively, these results support selective inhibition of these specific caspases as an effective therapeutic strategy for stroke.

AB - Despite extensive research to develop an effective neuroprotective strategy for the treatment of ischemic stroke, therapeutic options remain limited. Although caspase-dependent death is thought to play a prominent role in neuronal injury, direct evidence of active initiator caspases in stroke and the functional relevance of this activity have not previously been shown. Using an unbiased caspase-trapping technique in vivo, weisolated active caspase-9 from ischemic rat brain within 1 h of reperfusion. Pathogenic relevance of active caspase-9 was shown by intranasal delivery of a novel cell membrane-penetrating highly specific inhibitor for active caspase-9 at 4 h postreperfusion (hpr). Caspase-9 inhibition provided neurofunctional protection and established caspase-6 as its downstream target. The temporal and spatial pattern of expression demonstrates that neuronal caspase-9 activity induces caspase-6 activation, mediating axonal loss by 12 hpr followed by neuronal death within 24 hpr. Collectively, these results support selective inhibition of these specific caspases as an effective therapeutic strategy for stroke.

UR - http://www.scopus.com/inward/record.url?scp=79959314865&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959314865&partnerID=8YFLogxK

U2 - 10.1523/JNEUROSCI.0698-11.2011

DO - 10.1523/JNEUROSCI.0698-11.2011

M3 - Article

C2 - 21677173

AN - SCOPUS:79959314865

VL - 31

SP - 8894

EP - 8904

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 24

ER -